17.06
price down icon1.27%   -0.22
after-market 시간 외 거래: 17.06
loading
전일 마감가:
$17.28
열려 있는:
$17.36
하루 거래량:
79,427
Relative Volume:
0.84
시가총액:
$249.85M
수익:
$166.88M
순이익/손실:
$-74.18M
주가수익비율:
-3.3649
EPS:
-5.07
순현금흐름:
$1.14M
1주 성능:
+4.60%
1개월 성능:
+3.65%
6개월 성능:
-37.39%
1년 성능:
-27.47%
1일 변동 폭
Value
$16.98
$17.62
1주일 범위
Value
$16.19
$17.62
52주 변동 폭
Value
$15.40
$29.11

Anika Therapeutics Inc Stock (ANIK) Company Profile

Name
명칭
Anika Therapeutics Inc
Name
전화
(781) 457-9000
Name
주소
32 WIGGINS AVENUE, BEDFORD, MA
Name
직원
357
Name
트위터
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
ANIK's Discussions on Twitter

ANIK을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
ANIK
Anika Therapeutics Inc
17.06 249.85M 166.88M -74.18M 1.14M -5.07
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
170.90 77.10B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.47 42.82B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.39 42.45B 30.27B 1.93B 3.45B 0.6044
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.73 20.09B 16.77B -959.00M 1.37B -0.85
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
151.82 15.37B 2.24B 385.90M 440.10M 3.73

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-01 재확인 Barrington Research Outperform
2023-08-14 업그레이드 Barrington Research Mkt Perform → Outperform
2023-03-07 다운그레이드 Barrington Research Outperform → Mkt Perform
2022-11-09 업그레이드 Barrington Research Mkt Perform → Outperform
2022-10-14 재개 Stephens Equal-Weight
2022-03-09 다운그레이드 Barrington Research Outperform → Mkt Perform
2022-03-09 다운그레이드 Stephens Overweight → Equal-Weight
2021-11-16 개시 Stephens Overweight
2021-07-16 개시 UBS Neutral
2020-12-16 업그레이드 Barrington Research Mkt Perform → Outperform
2020-05-08 다운그레이드 Barrington Research Outperform → Mkt Perform
2020-01-21 업그레이드 Sidoti Neutral → Buy
2020-01-10 업그레이드 First Analysis Sec Outperform → Strong Buy
2019-11-05 개시 BWS Financial Sell
2019-09-24 재확인 Barrington Research Outperform
2019-09-23 다운그레이드 First Analysis Sec Strong Buy → Outperform
2019-07-25 업그레이드 First Analysis Sec Neutral → Strong Buy
2019-02-22 다운그레이드 First Analysis Sec Outperform → Neutral
2019-02-22 다운그레이드 Sidoti Buy → Neutral
2018-07-27 업그레이드 Barrington Research Mkt Perform → Outperform
2018-06-20 다운그레이드 Barrington Research Outperform → Mkt Perform
2018-06-20 다운그레이드 First Analysis Sec Overweight → Equal-Weight
2018-05-04 업그레이드 Barrington Research Mkt Perform → Outperform
2018-02-23 다운그레이드 Barrington Research Outperform → Mkt Perform
2018-01-24 업그레이드 First Analysis Sec Equal-Weight → Overweight
2017-10-27 재확인 Barrington Research Outperform
2016-05-09 업그레이드 Singular Research BUY - Long-Term → Buy
2016-04-27 다운그레이드 Northland Capital Outperform → Market Perform
2016-02-26 재확인 Barrington Research Outperform
모두보기

Anika Therapeutics Inc 주식(ANIK)의 최신 뉴스

pulisher
Jan 30, 2025

JPMorgan Chase & Co. Sells 11,072 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jan 30, 2025
pulisher
Jan 23, 2025

Dimensional Fund Advisors LP Reduces Stake in Anika Therapeutics Inc - GuruFocus.com

Jan 23, 2025
pulisher
Jan 22, 2025

Facial Aesthetics Market Generated Opportunities, Future - openPR

Jan 22, 2025
pulisher
Jan 17, 2025

Orthopedic Digit Implants Market: Share, Revenue Insights, - openPR

Jan 17, 2025
pulisher
Jan 16, 2025

Barclays PLC Purchases 13,054 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jan 16, 2025
pulisher
Jan 14, 2025

Viscosupplementation Market Generated Opportunities, Future - openPR

Jan 14, 2025
pulisher
Jan 13, 2025

(ANIK) Proactive Strategies - Stock Traders Daily

Jan 13, 2025
pulisher
Jan 07, 2025

Anika Therapeutics stock hits 52-week low at $15.8 By Investing.com - Investing.com Australia

Jan 07, 2025
pulisher
Jan 07, 2025

Anika Therapeutics stock hits 52-week low at $15.8 - Investing.com India

Jan 07, 2025
pulisher
Jan 05, 2025

Jane Street Group LLC Increases Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jan 05, 2025
pulisher
Jan 03, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Geode Capital Management LLC - Defense World

Jan 03, 2025
pulisher
Jan 01, 2025

Barclays PLC Buys 13,054 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Jan 01, 2025
pulisher
Dec 30, 2024

We Think Anika Therapeutics (NASDAQ:ANIK) Can Easily Afford To Drive Business Growth - Yahoo Finance

Dec 30, 2024
pulisher
Dec 28, 2024

State Street Corp Sells 7,667 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Dec 28, 2024
pulisher
Dec 23, 2024

Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Bought by HighTower Advisors LLC - Defense World

Dec 23, 2024
pulisher
Dec 23, 2024

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Dec 23, 2024
pulisher
Dec 23, 2024

Anika Therapeutics to Present at JPM Healthcare Conference 2025: Joint Preservation Leader Takes Stage - StockTitan

Dec 23, 2024
pulisher
Dec 23, 2024

(ANIK) On The My Stocks Page - Stock Traders Daily

Dec 23, 2024
pulisher
Dec 19, 2024

Fmr LLC Acquires 4,996 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Dec 19, 2024
pulisher
Dec 19, 2024

Improved Revenues Required Before Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Find Their Feet - Simply Wall St

Dec 19, 2024
pulisher
Dec 18, 2024

Anika Therapeutics stock hits 52-week low at $15.99 - Investing.com

Dec 18, 2024
pulisher
Dec 16, 2024

Verition Fund Management LLC Sells 1,763 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World

Dec 16, 2024
pulisher
Dec 14, 2024

Anika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest Update - MarketBeat

Dec 14, 2024
pulisher
Dec 11, 2024

Knee Osteoarthritis Market Projected CAGR 12.5% Dynamics - openPR

Dec 11, 2024
pulisher
Dec 05, 2024

Joint Pain Injection Market Expected to Reach Prominent Growth - openPR

Dec 05, 2024
pulisher
Nov 28, 2024

ANIK (Anika Therapeutics) Net Issuance of Preferred Stock : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 28, 2024
pulisher
Nov 26, 2024

Osteoarthritis Therapeutics Market Size to Reach USD 24.34 Bn by 2034 - GlobeNewswire Inc.

Nov 26, 2024
pulisher
Nov 23, 2024

Anika To Participate in December 2024 Investor Conferences - The Manila Times

Nov 23, 2024
pulisher
Nov 22, 2024

Anika Therapeutics to Present at Three Major Healthcare Investor Conferences in December | ANIK Stock News - StockTitan

Nov 22, 2024
pulisher
Nov 20, 2024

Orthopedic Regenerative Surgical Products Market to Witness - openPR

Nov 20, 2024
pulisher
Nov 19, 2024

Joint Pain Injection Market Size, Share, Trends, - openPR

Nov 19, 2024
pulisher
Nov 11, 2024

New Strong Sell Stocks for November 11th - Yahoo Canada Finance

Nov 11, 2024
pulisher
Nov 08, 2024

Orthobiologics Market Size, Growth, Opportunities 2024-2032 | - openPR

Nov 08, 2024
pulisher
Nov 06, 2024

Anika Therapeutics Navigates Geopolitical Risks Amid Global Conflicts - TipRanks

Nov 06, 2024
pulisher
Nov 05, 2024

Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Sold by Capital Management Corp VA - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Anika Therapeutics Announces Third Quarter Financial ResultsOn October 31, 2024, Anika Therapeutics, Inc. released a press statement unveiling its financial outcomes for the third quarter concluding on September 30, 2024. As per the report - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

Viscosupplementation Market Report Analysis, Growth - openPR

Nov 05, 2024
pulisher
Nov 04, 2024

Anika Therapeutics (NASDAQ:ANIK) Downgraded to Hold Rating by StockNews.com - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 04, 2024
pulisher
Nov 04, 2024

Barrington Research Cuts Anika Therapeutics (NASDAQ:ANIK) Price Target to $25.00 - Defense World

Nov 04, 2024
pulisher
Nov 03, 2024

Earnings call: Anika Therapeutics Focuses on HA Products Amid Restructuring By Investing.com - Investing.com South Africa

Nov 03, 2024
pulisher
Nov 03, 2024

Earnings call: Anika Therapeutics Focuses on HA Products Amid Restructuring - Investing.com

Nov 03, 2024
pulisher
Nov 02, 2024

Anika Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Nov 02, 2024
pulisher
Nov 02, 2024

Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

Anika Therapeutics (NASDAQ:ANIK) Given New $25.00 Price Target at Barrington Research - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Anika Therapeutics (NASDAQ:ANIK shareholders incur further losses as stock declines 30% this week, taking five-year losses to 72% - Simply Wall St

Nov 01, 2024
pulisher
Nov 01, 2024

Anika: Q3 Earnings Snapshot - New Haven Register

Nov 01, 2024
pulisher
Nov 01, 2024

Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Yahoo Finance UK

Nov 01, 2024
pulisher
Nov 01, 2024

Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Anika Therapeutics divests Arthrosurface, eyes Parcus sale - Investing.com India

Nov 01, 2024

Anika Therapeutics Inc (ANIK) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$31.53
price down icon 1.19%
$12.03
price down icon 3.53%
$92.51
price down icon 0.30%
$11.28
price down icon 1.23%
$127.08
price up icon 0.06%
$151.82
price down icon 0.96%
자본화:     |  볼륨(24시간):